Diagnostic approach to microcephaly in childhood: A two-center study and review of the literature

Developmental Medicine and Child Neurology

Volumn 56, Issue 8, 2014, Pages 732-741

  Von der Hagen, Maja ^a   Pivarcsi, Mark ^b   Liebe, Juliane ^a   von Bernuth, Horst ^b   Didonato, Nataliya ^a   Hennermann, Julia B ^b,c   Bührer, Christoph ^b   Wieczorek, Dagmar ^d   Kaindl, Angela M ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN DEVELOPMENT; CAUSAL ATTRIBUTION; CHILD; CHILDHOOD DISEASE; DISEASE ASSOCIATION; EPILEPSY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GERMANY; HUMAN; INFANT; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MICROCEPHALY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

CHILD, PRESCHOOL; COMORBIDITY; EPILEPSY; EYE DISEASES; FEMALE; GERMANY; HUMANS; INFANT; INTELLECTUAL DISABILITY; MALE; MICROCEPHALY; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES;

EID: 84904111529     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12425     Document Type: Article

References (50)

1. Opitz JM, Holt MC. Microcephaly: general considerations and aids to nosology. J Craniofac Genet Dev Biol 1990; 10: 175-204.
2. Woods CG. Human microcephaly. Curr Opin Neurobiol 2004; 14: 112-17.
3. Abuelo D. Microcephaly syndromes. Semin Pediatr Neurol 2007; 14: 118-27.
4. Leroy JG, Frias JL. Nonsyndromic microcephaly: an overview. Adv Pediatr 2005; 52: 261-93.
5. Holden KR, Lyons MJ. Microcephaly - acquired. Maria BL, editor. Current Management in Child Neurology. Shelton, CT: People's Medical Publishing House, 2009: 421-8.
6. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization, 1992.
7. Baxter PS, Rigby AS, Rotsaert MH, Wright I. Acquired microcephaly: causes, patterns, motor and IQ effects, and associated growth changes. Pediatrics 2009; 124: 590-5.
8. Stoler-Poria S, Lev D, Schweiger A, Lerman-Sagie T, Malinger G. Developmental outcome of isolated fetal microcephaly. Ultrasound Obstet Gynecol 2010; 36: 154-8.
9. Nelson KB, Deutschberger J. Head size at one year as a predictor of four-year IQ. Dev Med Child Neurol 1970; 12: 487-95.
10. Ivanovic DM, Leiva BP, Perez HT, et al. Head size and intelligence, learning, nutritional status and brain development. Head, IQ, learning, nutrition and brain. Neuropsychologia 2004; 42: 1118-31.
11. Gale CR, O'Callaghan FJ, Bredow M, Martyn CN. The influence of head growth in fetal life, infancy, and childhood on intelligence at the ages of 4 and 8 years. Pediatrics 2006; 118: 1486-92.
12. Hack M, Breslau N, Weissman B, Aram D, Klein N, Borawski E. Effect of very low birth weight and subnormal head size on cognitive abilities at school age. N Engl J Med 1991; 325: 231-7.
13. Ashwal S, Michelson D, Plawner L, Dobyns WB. Practice parameter: evaluation of the child with microcephaly (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2009; 73: 887-97.
14. Coronado R, Giraldo J, Macaya A, Roig M. Head circumference growth function as a marker of neurological impairment in a cohort of microcephalic infants and children. Neuropediatrics 2012; 43: 271-4.
15. Abdel-Salam GM, Halasz AA, Czeizel AE. Association of epilepsy with different groups of microcephaly. Dev Med Child Neurol 2000; 42: 760-7.
16. Qazi QH, Reed TE. A problem in diagnosis of primary versus secondary microcephaly. Clin Genet 1973; 4: 46-52.
17. Chawla S, Aneja S, Kashyap R, Mallika V. Aetiology and clinical predictors of intractable epilepsy. Pediatr Neurol 2002; 27: 186-91.
18. Dolk H. The predictive value of microcephaly during the first year of life for mental retardation at seven years. Dev Med Child Neurol 1991; 33: 974-83.
19. Glass HC, Shaw GM, Ma C, Sherr EH. Agenesis of the corpus callosum in California 1983-2003: a population-based study. Am J Med Genet A 2008; 146: 2495-500.
20. Paul LK. Developmental malformation of the corpus callosum: a review of typical callosal development and examples of developmental disorders with callosal involvement. J Neurodev Disord 2011; 3: 3-27.
21. Bodensteiner J, Schaefer GB, Breeding L, Cowan L. Hypoplasia of the corpus callosum: a study of 445 consecutive MRI scans. J Child Neurol 1994; 9: 47-9.
22. Verbruggen KT, Meiners LC, Sijens PE, Lunsing RJ, van Spronsen FJ, Brouwer OF. Magnetic resonance imaging and proton magnetic resonance spectroscopy of the brain in the diagnostic evaluation of developmental delay. Eur J Paediatr Neurol 2009; 13: 181-90.
23. Jaworski M, Hersh JH, Donat J, Shearer LT, Weisskopf B. Computed tomography of the head in the evaluation of microcephaly. Pediatrics 1986; 78: 1064-9.
24. Romano C. The clinical evaluation of patients with mental retardation/intellectual disability. Knight SJL, editor. Genetics of Mental Retardation. Basle: Karger, 2010: 57-66.
25. Shevell M, Ashwal S, Donley D, et al. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology 2003; 60: 367-80.
26. van Karnebeek CD, Houben RF, Lafek M, Giannasi W, Stockler S. The treatable intellectual disability APP www.treatable-id.org: a digital tool to enhance diagnosis & care for rare diseases. Orphanet J Rare Dis 2012; 7: 47.
27. van Karnebeek CD, Scheper FY, Abeling NG, et al. Etiology of mental retardation in children referred to a tertiary care center: a prospective study. Am J Ment Retard 2005; 110: 253-67.
28. Shevell MI, Majnemer A, Rosenbaum P, Abrahamowicz M. Etiologic yield of subspecialists' evaluation of young children with global developmental delay. J Pediatr 2000; 136: 593-8.
29. Dekaban AS. Changes in brain weights during the span of human life: relation of brain weights to body heights and body weights. Ann Neurol 1978; 4: 345-56.
30. Nellhaus G. Head circumference from birth to eighteen years. Practical composite international and interracial graphs. Pediatrics 1968; 41: 106-14.
31. Prader A, Largo RH, Molinari L, Issler C. Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta Suppl 1989; 52: 1-125.
32. Tabatabaie L, Klomp LW, Berger R, de Koning TJ. L-serine synthesis in the central nervous system: a review on serine deficiency disorders. Mol Genet Metab 2010; 99: 256-62.
33. Goldenberg A, Chevy F, Bernard C, Wolf C, Cormier-Daire V. [Clinical characteristics and diagnosis of Smith-Lemli-Opitz syndrome and tentative phenotype-genotype correlation: report of 45 cases. Arch Pediatr 2003; 10: 4-10.
34. Barnerias C, Saudubray JM, Touati G, et al. Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis. Dev Med Child Neurol 2010; 52: e1-9.
35. van Straaten HL, van Tintelen JP, Trijbels JM, et al. Neonatal lactic acidosis, complex I/IV deficiency, and fetal cerebral disruption. Neuropediatrics 2005; 36: 193-9.
36. Siu VM, Ratko S, Prasad AN, Prasad C, Rupar CA. Amish microcephaly: long-term survival and biochemical characterization. Am J Med Genet A 2010; 152: 1747-51.
37. Kranz C, Sun L, Eklund EA, Krasnewich D, Casey JR, Freeze HH. CDG-Id in two siblings with partially different phenotypes. Am J Med Genet A 2007; 143: 1414-20.
38. Schollen E, Grunewald S, Keldermans L, Albrecht B, Korner C, Matthijs G. CDG-Id caused by homozygosity for an ALG3 mutation due to segmental maternal isodisomy UPD3(q21.3-qter). Eur J Med Genet 2005; 48: 153-8.
39. Morava E, Vodopiutz J, Lefeber DJ, et al. Defining the phenotype in congenital disorder of glycosylation due to ALG1 mutations. Pediatrics 2012; 130: e1034-9.
40. Morava E, Zeevaert R, Korsch E, et al. A common mutation in the COG7 gene with a consistent phenotype including microcephaly, adducted thumbs, growth retardation, VSD and episodes of hyperthermia. Eur J Hum Genet 2007; 15: 638-45.
41. Chenel C, Wood C, Gourrier E, Zittoun J, Casadevall I, Ogier H. [Neonatal haemolytic-uraemic syndrome, methylmalonic aciduria and homocystinuria caused by intracellular vitamin B 12 deficiency. Value of aetiological diagnosis]. Arch Fr Pediatr 1993; 50: 749-54.
42. 12 metabolism in a Turkish patient. J Inherit Metab Dis 2010; 33: 17-24.
43. Busche A, Hennermann JB, Burger F, et al. Neonatal manifestation of multiple sulfatase deficiency. Eur J Pediatr 2009; 168: 969-73.
44. Fritchie K, Siintola E, Armao D, et al. Novel mutation and the first prenatal screening of cathepsin D deficiency (CLN10). Acta Neuropathol 2009; 117: 201-8.
45. Mayatepek E, Flock B. Leukotriene C4-synthesis deficiency: a new inborn error of metabolism linked to a fatal developmental syndrome. Lancet 1998; 352: 1514-17.
46. Carmi-Nawi N, Malinger G, Mandel H, Ichida K, Lerman-Sagie T, Lev D. Prenatal brain disruption in molybdenum cofactor deficiency. J Child Neurol 2011; 26: 460-4.
47. Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011; 43: 838-46.
48. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86: 749-64.
49. Shoukier M, Klein N, Auber B, et al. Array CGH in patients with developmental delay or intellectual disability: are there phenotypic clues to pathogenic copy number variants? Clin Genet 2013; 83: 53-65.
50. Kaindl AM, Passemard S, Kumar P, et al. Many roads lead to primary autosomal recessive microcephaly. Prog Neurobiol 2010; 90: 363-83.